FY23 consensus $2.52. Raises FY23 revenue at high end of $5.6B-$6B range, consensus $5.85B.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on EW:
- Edwards Lifesciences price target raised to $95 from $85 at Mizuho
- Edwards Lifesciences price target raised to $87 from $75 at Stifel
- Edwards Lifesciences price target raised to $93 from $86 at Truist
- Edwards Lifesciences price target raised to $97 from $92 at Citi
- Citi opens two positive, one negative catalyst watches in medical technology